Phase I/II clinical trial of the targeted chemotherapeutic drug, folate-tubulysin, in dogs with naturally-occurring invasive urothelial carcinoma

por Szigetvari, Nicholas M., Dhawan, Deepika, Ramos-Vara, José A., Leamon, Christopher P., Klein, Patrick J., Ruple, A. Audrey, Heng, Hock Gan, Pugh, Michael R., Rao, Satish, Vlahov, Iontcho R., Deshuillers, Pierre L., Low, Philip S., Fourez, Lindsey M., Cournoyer, Ashleigh M., Knapp, Deborah W.
Publicado 2018

Identification of a naturally-occurring canine model for early detection and intervention research in high grade urothelial carcinoma

por Dhawan, Deepika, Ramos-Vara, José A., Utturkar, Sagar M., Ruple, Audrey, Tersey, Sarah A., Nelson, Jennifer B., Cooper, Bruce R., Heng, Hock Gan, Ostrander, Elaine A., Parker, Heidi G., Hahn, Noah M., Adams, Larry G., Fulkerson, Christopher M., Childress, Michael O., Bonney, Patty L., Royce, Christine, Fourez, Lindsey M., Enstrom, Alexander W., Ambrosius, Lisbeth A., Knapp, Deborah W.
Publicado 2022